American Health Packaging – Recall of ranitidine
February 27, 2020 - American Health Packaging announced a voluntary, consumer-level recall of prescription ranitidine tablets because of the potential presence of N-nitrosodimethylamine (NDMA) levels above the acceptable daily intake levels established by the FDA.
Top